 this is a question for the second quarter of 2019 earnings conference call.    
 we are reporting a solid financial performance for the second quarter of 2019 with net income of $53.8 million or $0.61 per diluted share, excluding transaction-related expenses of $5.2 million and an income tax effect of adjustments to income of $0.4 million based on a tax rate of 17.2%.    
 we added 118 beds in the second quarter, including 72 new beds in existing facilities and 46 beds resulting from the acquisition of Bradford Recovery Center, a specialty treatment facility located in Millerton, Pennsylvania.    
 our U.S. same facility revenue increased 6.6% for the second quarter, with a 3.3% increase in patient days and a 3.2% increase in revenue per patient day compared with the prior year period.    
 same facility margin increased by 150 basis points sequentially to 17.8%.    
 we also added a 44-bed expansion at Sierra Tucson in late 2018 and that has exceeded our census projections.    
 we did see losses from those de novos over the course of the second quarter,